| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/TPJ.2012.32 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/tpj.2012.32 |
| P932 | PMC publication ID | 3941038 |
| P698 | PubMed publication ID | 22907730 |
| P5875 | ResearchGate publication ID | 230711930 |
| P50 | author | Yu-Bo Chai | Q73806612 |
| P2093 | author name string | R M Weinshilboum | |
| Y Nakamura | |||
| N Kamatani | |||
| Y Ji | |||
| K A Snyder | |||
| M Kubo | |||
| D Flockhart | |||
| Z Desta | |||
| A Batzler | |||
| J M Biernacka | |||
| T Mushiroda | |||
| D Schaid | |||
| D A Mrazek | |||
| M S Drews | |||
| G D Jenkins | |||
| S Hebbring | |||
| P2860 | cites work | Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia | Q24308818 |
| Inference of population structure using multilocus genotype data | Q24548114 | ||
| A genomewide association study of citalopram response in major depressive disorder | Q24656746 | ||
| PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
| Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
| G protein-coupled receptor kinase 5 regulates beta 1-adrenergic receptor association with PSD-95 | Q28204363 | ||
| Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations | Q28259237 | ||
| A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose | Q28475004 | ||
| The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
| Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice | Q29614979 | ||
| Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials | Q30998754 | ||
| Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy | Q34019082 | ||
| Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines | Q34239148 | ||
| Association of G72/G30 with schizophrenia in the Chinese population | Q34326702 | ||
| Genome-wide association studies in pharmacogenomics: successes and lessons | Q34415006 | ||
| The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis | Q34482845 | ||
| Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors | Q34488758 | ||
| Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients | Q34527912 | ||
| Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics | Q34555598 | ||
| Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder | Q34871885 | ||
| Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response | Q35040545 | ||
| Genome-wide association studies of antidepressant outcome: a brief review | Q35074796 | ||
| A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression | Q35737324 | ||
| The methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism | Q35752594 | ||
| The pharmacogenomics of selective serotonin reuptake inhibitors. | Q35757723 | ||
| A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure | Q37000342 | ||
| Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice | Q37369510 | ||
| SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A. | Q37437784 | ||
| Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises | Q37914472 | ||
| Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases | Q41227485 | ||
| Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients | Q42471862 | ||
| Genome-wide pharmacogenetics of antidepressant response in the GENDEP project | Q42655084 | ||
| Dietary folate, riboflavin, vitamin B-6, and vitamin B-12 and depressive symptoms in early adolescence: the Ryukyus Child Health Study | Q42934810 | ||
| One-carbon metabolism disturbances in affective disorders. A preliminary report | Q45394158 | ||
| Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified | Q47664212 | ||
| Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder | Q48301418 | ||
| Methylation and mood | Q48643166 | ||
| The HTR1A and HTR1B receptor genes influence stress-related information processing. | Q49122883 | ||
| Interactive effects of DAOA (G72) and catechol-O-methyltransferase on neurophysiology in prefrontal cortex. | Q51024502 | ||
| Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. | Q51034630 | ||
| Association analysis of DAOA and DAO in bipolar disorder: results from two independent case-control studies | Q57428767 | ||
| Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice | Q61711338 | ||
| Abnormalities of one-carbon metabolism in psychiatric disorders: study of methionine adenosyltransferase kinetics and lipid composition of erythrocyte membranes | Q69685460 | ||
| Association between the 5-HTR1B gene polymorphisms and alcohol dependence in a Han Chinese population | Q82963810 | ||
| The pharmacogenetics of depression: enter the GWAS | Q84150435 | ||
| P433 | issue | 5 | |
| P921 | main subject | major depressive disorder | Q42844 |
| serotonin | Q167934 | ||
| genomics | Q222046 | ||
| functional genomics | Q1068690 | ||
| genome-wide association study | Q1098876 | ||
| pharmacogenomics | Q1152227 | ||
| P304 | page(s) | 456-463 | |
| P577 | publication date | 2012-08-21 | |
| P1433 | published in | The Pharmacogenomics Journal | Q10534704 |
| P1476 | title | Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics | |
| P478 | volume | 13 |
| Q28597255 | A genome-wide association study of antidepressant response in Koreans |
| Q31130220 | Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response |
| Q89581651 | Association of Novel ALX4 Gene Polymorphisms with Antidepressant Treatment Response: Findings from the CO-MED Trial |
| Q38540142 | BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients. |
| Q47659995 | Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics. |
| Q34065310 | Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations |
| Q40269228 | Detecting Associations between Major Depressive Disorder Treatment and Essential Hypertension using Electronic Health Records |
| Q90816200 | Dual Roles for the TSPYL Family in Mediating Serotonin Transport and the Metabolism of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder |
| Q102369303 | ERICH3: vesicular association and antidepressant treatment response |
| Q28083508 | Ethical and public policy challenges for pharmacogenomics |
| Q31104563 | Evaluation of methodology for the analysis of 'time-to-event' data in pharmacogenomic genome-wide association studies |
| Q37199719 | FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder |
| Q37640340 | Genetic and biochemical changes of the serotonergic system in migraine pathobiology |
| Q101237251 | Genome-wide association studies of antidepressant class response and treatment-resistant depression |
| Q34254863 | Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia |
| Q93012838 | Influence of GRK5 gene polymorphisms on ritodrine efficacy and adverse drug events in preterm labor treatment |
| Q30885784 | Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions |
| Q91622024 | Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients |
| Q47118154 | MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action |
| Q47572666 | Multivariate generalized linear model for genetic pleiotropy. |
| Q47436767 | New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation. |
| Q35040224 | PDYN rs2281285 variant association with drinking to avoid emotional or somatic discomfort |
| Q38657429 | Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks |
| Q90224430 | Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication |
| Q37158262 | Pharmacometabolomics informs Pharmacogenomics |
| Q35032056 | Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology. |
| Q57303389 | Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts |
| Q47666907 | Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years |
| Q47796188 | Serotonin in psychiatry: in vitro disease modeling using patient-derived neurons |
| Q45022135 | Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014. |
| Q64249357 | Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk |
| Q47912001 | Systems genetics analysis of pharmacogenomics variation during antidepressant treatment. |
| Q37213132 | TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics |
| Q35715254 | The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response. |
Search more.